339 related articles for article (PubMed ID: 26774404)
1. FNDC5 relates to skeletal muscle IGF-I and mitochondrial function and gene expression in obese men with reduced growth hormone.
Srinivasa S; Suresh C; Mottla J; Hamarneh SR; Irazoqui JE; Frontera W; Torriani M; Stanley T; Makimura H
Growth Horm IGF Res; 2016 Feb; 26():36-41. PubMed ID: 26774404
[TBL] [Abstract][Full Text] [Related]
2. Relationship between serum IGF-1 and skeletal muscle IGF-1 mRNA expression to phosphocreatine recovery after exercise in obese men with reduced GH.
Hamarneh SR; Murphy CA; Shih CW; Frontera W; Torriani M; Irazoqui JE; Makimura H
J Clin Endocrinol Metab; 2015 Feb; 100(2):617-25. PubMed ID: 25375982
[TBL] [Abstract][Full Text] [Related]
3. The role of sex, adiposity, and gonadectomy in the regulation of irisin secretion.
Zügel M; Qiu S; Laszlo R; Bosnyák E; Weigt C; Müller D; Diel P; Steinacker JM; Schumann U
Endocrine; 2016 Oct; 54(1):101-110. PubMed ID: 27055554
[TBL] [Abstract][Full Text] [Related]
4. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance.
Moreno-Navarrete JM; Ortega F; Serrano M; Guerra E; Pardo G; Tinahones F; Ricart W; Fernández-Real JM
J Clin Endocrinol Metab; 2013 Apr; 98(4):E769-78. PubMed ID: 23436919
[TBL] [Abstract][Full Text] [Related]
5. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise.
Huh JY; Panagiotou G; Mougios V; Brinkoetter M; Vamvini MT; Schneider BE; Mantzoros CS
Metabolism; 2012 Dec; 61(12):1725-38. PubMed ID: 23018146
[TBL] [Abstract][Full Text] [Related]
6. Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health?
Pekkala S; Wiklund PK; Hulmi JJ; Ahtiainen JP; Horttanainen M; Pöllänen E; Mäkelä KA; Kainulainen H; Häkkinen K; Nyman K; Alén M; Herzig KH; Cheng S
J Physiol; 2013 Nov; 591(21):5393-400. PubMed ID: 24000180
[TBL] [Abstract][Full Text] [Related]
7. Exercise-mimicking treatment fails to increase Fndc5 mRNA & irisin secretion in primary human myotubes.
Kurdiova T; Balaz M; Mayer A; Maderova D; Belan V; Wolfrum C; Ukropec J; Ukropcova B
Peptides; 2014 Jun; 56():1-7. PubMed ID: 24642356
[TBL] [Abstract][Full Text] [Related]
8. Elevated skeletal muscle irisin precursor FNDC5 mRNA in obese OLETF rats.
Roberts MD; Bayless DS; Company JM; Jenkins NT; Padilla J; Childs TE; Martin JS; Dalbo VJ; Booth FW; Rector RS; Laughlin MH
Metabolism; 2013 Aug; 62(8):1052-6. PubMed ID: 23498898
[TBL] [Abstract][Full Text] [Related]
9. SMAD3 negatively regulates serum irisin and skeletal muscle FNDC5 and peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) during exercise.
Tiano JP; Springer DA; Rane SG
J Biol Chem; 2015 Mar; 290(12):7671-84. PubMed ID: 25648888
[TBL] [Abstract][Full Text] [Related]
10. Circulating irisin levels and muscle FNDC5 mRNA expression are independent of IL-15 levels in mice.
Quinn LS; Anderson BG; Conner JD; Wolden-Hanson T
Endocrine; 2015 Nov; 50(2):368-77. PubMed ID: 25920499
[TBL] [Abstract][Full Text] [Related]
11. The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans.
Norheim F; Langleite TM; Hjorth M; Holen T; Kielland A; Stadheim HK; Gulseth HL; Birkeland KI; Jensen J; Drevon CA
FEBS J; 2014 Feb; 281(3):739-49. PubMed ID: 24237962
[TBL] [Abstract][Full Text] [Related]
12. Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status.
Savastano S; Di Somma C; Colao A; Barrea L; Orio F; Finelli C; Pasanisi F; Contaldo F; Tarantino G
Growth Horm IGF Res; 2015 Feb; 25(1):28-33. PubMed ID: 25466907
[TBL] [Abstract][Full Text] [Related]
13. Time-Dependent Changes in Increased Levels of Plasma Irisin and Muscle PGC-1α and FNDC5 after Exercise in Mice.
Pang M; Yang J; Rao J; Wang H; Zhang J; Wang S; Chen X; Dong X
Tohoku J Exp Med; 2018 Feb; 244(2):93-103. PubMed ID: 29415899
[TBL] [Abstract][Full Text] [Related]
14. Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies.
Kurdiova T; Balaz M; Vician M; Maderova D; Vlcek M; Valkovic L; Srbecky M; Imrich R; Kyselovicova O; Belan V; Jelok I; Wolfrum C; Klimes I; Krssak M; Zemkova E; Gasperikova D; Ukropec J; Ukropcova B
J Physiol; 2014 Mar; 592(5):1091-107. PubMed ID: 24297848
[TBL] [Abstract][Full Text] [Related]
15. The effects of tesamorelin on phosphocreatine recovery in obese subjects with reduced GH.
Makimura H; Murphy CA; Feldpausch MN; Grinspoon SK
J Clin Endocrinol Metab; 2014 Jan; 99(1):338-43. PubMed ID: 24178787
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone treatment prevents the decrease in insulin-like growth factor I gene expression in patients undergoing abdominal surgery.
Bjarnason R; Wickelgren R; Hermansson M; Hammarqvist F; Carlsson B; Carlsson LM
J Clin Endocrinol Metab; 1998 May; 83(5):1566-72. PubMed ID: 9589657
[TBL] [Abstract][Full Text] [Related]
17. Decreased irisin secretion contributes to muscle insulin resistance in high-fat diet mice.
Yang Z; Chen X; Chen Y; Zhao Q
Int J Clin Exp Pathol; 2015; 8(6):6490-7. PubMed ID: 26261526
[TBL] [Abstract][Full Text] [Related]
18. A comparative study on the effects of high-fat diet and endurance training on the PGC-1α-FNDC5/irisin pathway in obese and nonobese male C57BL/6 mice.
Kazeminasab F; Marandi SM; Ghaedi K; Safaeinejad Z; Esfarjani F; Nasr-Esfahani MH
Appl Physiol Nutr Metab; 2018 Jul; 43(7):651-662. PubMed ID: 29365291
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of MgSO
Yazdanimoghaddam F; Aghaei M; Ghasemi M; Soltani N; Rezazadeh H; Zadhoush F
Mol Biol Rep; 2022 Apr; 49(4):2795-2803. PubMed ID: 35064400
[TBL] [Abstract][Full Text] [Related]
20. The association of growth hormone parameters with skeletal muscle phosphocreatine recovery in adult men.
Makimura H; Stanley TL; Sun N; Hrovat MI; Systrom DM; Grinspoon SK
J Clin Endocrinol Metab; 2011 Mar; 96(3):817-23. PubMed ID: 21177784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
